Cargando…

Enhancement of blood-tumor barrier permeability by Sar-[D-Phe8]des-Arg9BK, a metabolically resistant bradykinin B1 agonist, in a rat C6 glioma model

BACKGROUND: While it is well known that bradykinin B2 agonists increase plasma protein extravasation (PPE) in brain tumors, the bradykinin B1 agonists tested thus far are unable to produce this effect. Here we examine the effect of the selective B1 agonist bradykinin (BK) Sar-[D-Phe8]des-Arg9BK (SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardoso, Ronie Cleverson, Lobão-Soares, Bruno, Bianchin, Marino Muxfeldt, Carlotti, Carlos Gilberto, Walz, Roger, Alvarez-Silva, Márcio, Trentin, Andréa Gonçalves, Nicolau, Mauro
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524173/ https://www.ncbi.nlm.nih.gov/pubmed/15458573 http://dx.doi.org/10.1186/1471-2202-5-38

Ejemplares similares

D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
por: Bachelard, Hélène, et al.
Publicado: (2018)

Sono-Assembly of the [Arg-Phe](4) Octapeptide into Biofunctional Nanoparticles
por: Baral, Anshul, et al.
Publicado: (2020)

Arg-Phe-amide-related peptides influence gonadotropin-releasing hormone neurons
por: Kelestimur, Haluk, et al.
Publicado: (2013)

Phe-Met-Arg-Phe-amide Activates a Novel Voltage-dependent K(+) Current through a Lipoxygenase Pathway in Molluscan Neurones
por: Kits, K.S., et al.
Publicado: (1997)

The des-Arg(9)-bradykinin/B1R axis: Hepatic damage in COVID-19
por: Mendes, Gabriel Moreira de M, et al.
Publicado: (2022)

Type 2 Diabetes Elicits Lower Nitric Oxide, Bradykinin Concentration and Kallikrein Activity Together with Higher DesArg(9)-BK and Reduced Post-Exercise Hypotension Compared to Non-Diabetic Condition
por: Simões, Herbert Gustavo, et al.
Publicado: (2013)

Coronavirus IBV: Partial amino terminal sequencing of spike polypeptide S2 identifies the sequence Arg-Arg-Phe-Arg-Arg at the cleavage site of the spike precursor propolypeptide of IBV strains Beaudette and M41
por: Cavanagh, David, et al.
Publicado: (1986)

Rational Design and Characterization of D-Phe-Pro-D-Arg-Derived Direct Thrombin Inhibitors
por: Figueiredo, Ana C., et al.
Publicado: (2012)

Redox Regulation of Microvascular Permeability: IL-1β Potentiation of Bradykinin-Induced Permeability Is Prevented by Simvastatin
por: Freitas, Felipe, et al.
Publicado: (2020)

Bradykinin/bradykinin 1 receptor promotes brain microvascular endothelial cell permeability and proinflammatory cytokine release by downregulating Wnt3a
por: Huang, Linqiang, et al.
Publicado: (2022)

Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis
por: Schuster, Sabine, et al.
Publicado: (2019)

Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia–reperfusion
por: Woodfin, Abigail, et al.
Publicado: (2011)

In Vivo Effects of Bradykinin B(2) Receptor Agonists with Varying Susceptibility to Peptidases
por: Jean, Mélissa, et al.
Publicado: (2016)

The bradykinin BK2 receptor mediates angiotensin II receptor type 2 stimulated rat duodenal mucosal alkaline secretion
por: Ewert, Sara, et al.
Publicado: (2003)

Importance of Solvent-Bridged Structures of Fluorinated Diphenylalanines: Synthesis, Detailed NMR Analysis, and Rotational Profiles of Phe(2-F)-Phe(2-F), Phe(2-F)-Phe, and Phe-Phe(2-F)
por: Yang, Kaidi, et al.
Publicado: (2022)

Involvement of bradykinin and bradykinin B1 receptor in patients with endometriosis
por: Meng, Xin, et al.
Publicado: (2021)

Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
por: Sharma, J. N., et al.
Publicado: (2006)

The Phe-Phe Motif for Peptide Self-Assembly in Nanomedicine
por: Marchesan, Silvia, et al.
Publicado: (2015)

Heterochirality and Halogenation Control Phe-Phe Hierarchical Assembly
por: Kralj, Slavko, et al.
Publicado: (2020)

State-dependent inhibition of BK channels by the opioid agonist loperamide
por: Vouga, Alexandre G., et al.
Publicado: (2021)

Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons
por: Yi, Jiwon, et al.
Publicado: (2023)

Low Ang-(1–7) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19
por: Rostamzadeh, Farzaneh, et al.
Publicado: (2023)

Neprilysin Inhibitors and Bradykinin
por: Campbell, Duncan J.
Publicado: (2018)

Potentiation of bradykinin actions by analogues of the bradykinin potentiating nonapeptide BPP(9α)
por: Mueller, Sylvia, et al.
Publicado: (2005)

Non‐pulmonary CFTR‐related symptom improvement with ivacaftor in p.Phe508del/p.Arg117His (7T) cystic fibrosis
por: Kuek, Stephanie L., et al.
Publicado: (2022)

Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign
por: Gomez-Gutierrez, Patricia, et al.
Publicado: (2020)

ICTR-PHE 2016
por: Brice, Maximilien
Publicado: (2016)

ICTR-PHE 2014
por: Pantelia, Anna
Publicado: (2014)

Phe–Phe Di-Peptide Nanostructure Self-Assembling Modulated by Luminescent Additives
por: Ribeiro, Antonio C. C., et al.
Publicado: (2019)

The Role of Active-Site Residues Phe98, His239, and Arg243 in DNA Binding and in the Catalysis of Human Uracil–DNA Glycosylase SMUG1
por: Iakovlev, Danila A., et al.
Publicado: (2019)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Cardiovascular Activities of of the bradykinin system
por: Sharma, Jagdish N.
Publicado: (2008)

Cellular localization of kinin B(1 )receptor in the spinal cord of streptozotocin-diabetic rats with a fluorescent [N(α)-Bodipy]-des-Arg(9)-bradykinin
por: Talbot, Sébastien, et al.
Publicado: (2009)

Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B(2) receptor agonists
por: Charest-Morin, Xavier, et al.
Publicado: (2014)

Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine
por: Zhang, Xiaoyi, et al.
Publicado: (2020)

The role of polymorphic variants of arginase genes (ARG1, ARG2) involved in beta-2-agonist metabolism in the development and course of asthma
por: Savelieva, O.N., et al.
Publicado: (2020)

A Novel Bradykinin-Related Peptide, RVA-Thr(6)-BK, from the Skin Secretion of the Hejiang Frog; Ordorrana hejiangensis: Effects of Mammalian Isolated Smooth Muscle
por: Wu, Yue, et al.
Publicado: (2019)

Evaluating the Association of Calcified Neurocysticercosis and Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis in a Large Cohort of Patients With Epilepsy
por: Secchi, Thaís Leite, et al.
Publicado: (2022)

Cyclohexamer [-(d-Phe-azaPhe-Ala)(2)-]: good candidate to formulate supramolecular organogels
por: Ibrahim, Mohamed I. A., et al.
Publicado: (2020)

BK channel agonist represents a potential therapeutic approach for lysosomal storage diseases
por: Zhong, Xi Zoë, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5ubf442nc7grtiuclctmsj6917